Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19

被引：0
|
作者：
Burger, B. [1 ]
Epps, S. [2 ]
Cardenas, V. M. [3 ]
Meena, N. K. [2 ]
Jagana, R. [2 ]
Atchley, W. T. [2 ]
机构：
[1] Univ Arkansas Med Sci, Internal Med, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Pulm & Crit Care Med, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Epidemiol, Little Rock, AR 72205 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2635
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
    Burger, Barrett J.
    Epps, Sarenthia M.
    Cardenas, Victor M.
    Jagana, Rajani
    Meena, Nikhil K.
    Atchley, William T.
    [J]. LIFE-BASEL, 2023, 13 (08):
  • [2] Risk factors associated with bloodstream infections among critically ill patients with COVID-19
    McMillan, Tim
    Jones, Conor
    O'Connor, Cavan J.
    Nolan, Daniel
    Chan, Xin Hui S.
    Ellis, Jayne
    Thakker, Clare
    Kranzer, Katharina
    Stone, Neil R. H.
    Singer, Mervyn
    Wilson, A. Peter R.
    Arulkumaran, Nishkantha
    [J]. JOURNAL OF INFECTION, 2021, 83 (05) : E1 - E3
  • [3] Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum
    Rovina, Nikoletta
    Koukaki, Evangelia
    Romanou, Vasiliki
    Ampelioti, Sevasti
    Loverdos, Konstantinos
    Chantziara, Vasiliki
    Koutsoukou, Antonia
    Dimopoulos, George
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [4] Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients
    Raffaelli, Francesca
    Tanzarella, Eloisa Sofia
    De Pascale, Gennaro
    Tumbarello, Mario
    [J]. JOURNAL OF FUNGI, 2022, 8 (04)
  • [5] Severe mold fungal infections in critically ill patients with COVID-19
    Koulenti, Despoina
    Paramythiotou, Elisabeth
    Almyroudi, Maria Panagiota
    Karvouniaris, Marios
    Markou, Nikolaos
    Paranos, Paschalis
    Routsi, Christina
    Meletiadis, Joseph
    Blot, Stijn
    [J]. FUTURE MICROBIOLOGY, 2024, 19 (08) : 697 - 714
  • [6] MORTALITY AMONG CRITICALLY ILL PATIENTS WITH COVID-19 WHO RECEIVED TOCILIZUMAB
    Kruer, Rachel
    Tran, Mya
    Pollander, Abby
    Fadel, William
    Desai, Armisha
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 111 - 111
  • [7] Tocilizumab is associated with reduced delirium and coma in critically ill patients with COVID-19
    Alkhateeb, Tuqa
    Stollings, Joanna L.
    Sohn, Ine
    Liu, Dandan
    Fleenor, L. Montana
    Ely, E. Wesley
    Lahiri, Shouri
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
    Camou, Fabrice
    Issa, Nahema
    Hessamfar, Mojgan
    Guisset, Olivier
    Mourissoux, Gaelle
    Pedeboscq, Stephane
    Minot, Aimee
    Bonnet, Fabrice
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [9] EVALUATION OF THE EFFICACY OF TOCILIZUMAB IN CRITICALLY ILL COVID-19 PATIENTS
    Riggs, Kayla
    Patel, Vishal
    Pittiglio, Marina
    Cavanaugh, Joseph
    Sullivan, Jesse
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 141 - 141
  • [10] The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid-19
    Alshammary, Amal F.
    AlQarni, Hassan M.
    Farzan, Raed
    Khan, Imran Ali
    Vennu, Vishal
    [J]. CLINICAL RESPIRATORY JOURNAL, 2023, 17 (06): : 580 - 588
12345